Is aclidinium alone or combined with a LABA a rational choice for symptomatic COPD patients?
详细信息 查看全文
- 作者：F. Blasi ; G. W. Canonica ; M. Miravitlles
- 关键词：COPD ; Bronchodilators ; Symptoms ; Circadian variability ; Therapeutic control ; LAMA ; Aclidinium ; LAMA + LABA ; Aclidinium + formoterol
- 刊名：Respiratory Research
- 出版年：2017
- 出版时间：December 2017
- 年：2017
- 卷：18
- 期：1
- 全文大小：887KB
- 刊物主题：Pneumology/Respiratory System;
- 出版者：BioMed Central
- ISSN：1465-993X
- 卷排序：18
文摘
BackgroundAs emphasized by international recommendations and largely confirmed by clinical experience, long-acting bronchodilators play a central role in the maintenance treatment of chronic obstructive pulmonary disease (COPD) due to their proven efficacy in reducing airflow obstruction and improving symptoms.